Moleculin Biotech (MBRX) Institutional Ownership $2.67 +0.05 (+1.91%) (As of 05:27 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)CurrentInstitutional OwnershipPercentage15.52%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$41.97MNumber ofInstitutional Sellers(last 12 months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBRX Institutional Buying and Selling by Quarter Ad Resource Stock DigestThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best names in the lithium space will be set for escalating gains in 2025 and beyond. It’s all being driven by the global EV boom as millions of drivers ditch their gasoline-chugging cars and trucks in favor of lithium-ion-powered vehicles in record numbers. Everything you need to know is in our FREE online lithium report you can get here. Moleculin Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC156,000$549K0.0%+5.1%6.747% 2/13/2024 Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600% 1/17/2024 Atticus Wealth Management LLC50,001$43K0.0%N/A0.168% 5/15/2023 Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407% 7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072% 4/20/2022 Sigma Planning Corp57,500$102K0.0%+33.7%0.201% Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/2/2022 Sigma Planning Corp43,000$80K0.0%N/A0.150% 11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947% 9/17/2021Virtu Financial LLC25,302$93K0.0%N/A0.089% 8/16/2021 Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102% 8/16/2021 State Street Corp59,900$220K0.0%N/A0.210% 8/13/2021 Geode Capital Management LLC237,586$871K0.0%+35.9%0.835% 8/13/2021 Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683% 8/12/2021 XTX Topco Ltd32,997$121K0.0%N/A0.116% 8/5/2021 GSA Capital Partners LLP31,120$114K0.0%N/A0.109% 5/21/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/19/2021 Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102% 5/18/2021 Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094% 5/18/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/14/2021 Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078% 5/12/2021 Northern Trust Corp50,731$207K0.0%-43.1%0.178% 5/12/2021 Geode Capital Management LLC174,822$713K0.0%-40.6%0.615% 5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841% 4/27/2021 Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035% 4/14/2021 Taylor Cottrill Erickson & Associates Inc.16,964$69K0.0%-83.3%0.060% 2/10/2021 Renaissance Technologies LLC948,503$756K0.0%+6.4%7.901% 11/13/2020 Truist Financial Corp175,000$142K0.0%+25.0%0.284% (Data available from 1/1/2016 forward) MBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Sio Capital Management LLC ($971K), and Armistice Capital LLC ($549K), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors. What percentage of Moleculin Biotech stock is owned by institutional investors? 15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings. Which institutional investors have been buying Moleculin Biotech stock? The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), and Atticus Wealth Management LLC ($50.00K). How much institutional buying is happening at Moleculin Biotech? Institutional investors have bought a total of 3,264,923 shares in the last 24 months. This purchase volume represents approximately $41.97M in transactions. Which Moleculin Biotech major shareholders have been selling company stock? The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K). How much institutional selling is happening at Moleculin Biotech? Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions. Related Companies PASG Institutional Ownership LTRN Institutional Ownership ACST Institutional Ownership BIVI Institutional Ownership LIAN Institutional Ownership CTXR Institutional Ownership KALA Institutional Ownership SRZN Institutional Ownership RNXT Institutional Ownership MRKR Institutional Ownership This page (NASDAQ:MBRX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBRX Stock Alerts